Adalimumab persistence for inflammatory bowel disease in veteran and insured cohorts

Shail M. Govani, Rachel Lipson, Mohamed Noureldin, Wyndy Wiitala, Peter D.R. Higgins, Sameer D. Saini, Jacqueline A. Pugh, Dawn I. Velligan, Ryan W. Stidham, Akbar K. Waljee

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
JournalAmerican Journal of Managed Care
Volume24
Issue number12
StatePublished - Dec 2018

ASJC Scopus subject areas

  • Health Policy

Cite this

Govani, S. M., Lipson, R., Noureldin, M., Wiitala, W., Higgins, P. D. R., Saini, S. D., Pugh, J. A., Velligan, D. I., Stidham, R. W., & Waljee, A. K. (2018). Adalimumab persistence for inflammatory bowel disease in veteran and insured cohorts. American Journal of Managed Care, 24(12).